Locar Delivery    Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform Catheter Cardiovasc Interv (2009) 73; 597-604 C. A. Thompson, B. Huibregtse, B. Poff and G. J. Wilson Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med (2008) 358; 689-99 G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwalder, J. P. Beregi, C. D. Claussen, A. Oldenburg, B. Scheller and U. Speck Local paclitaxel delivery in peripheral vascular disease N Engl J Med (2008) 358; 2406; author reply 07 M. Schillinger and E. Minar Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction Heart (2008) 94; 604-9 H. J. Kang, Y. S. Kim, B. K. Koo, K. W. Park, H. Y. Lee, D. W. Sohn, B. H. Oh, Y. B. Park and H. S. Kim How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study Circulation (2008) 117; 598-604 S. L. Hardoon, P. H. Whincup, L. T. Lennon, S. G. Wannamethee, S. Capewell and R. W. Morris Local paclitaxel delivery in peripheral vascular disease N Engl J Med (2008) 358; 2406-7; author reply 07 N. Diehm, I. Baumgartner and P. Juni